X
Record #24374

High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey

Publisher
Springer
Original paper date
Nov 16, 2019
Institution
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan · Department of Hematology and Oncology, Okinawa Chubu Hospital, Uruma, Japan · Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan · Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan · Department of Hematology and Oncology, Niigata Cancer Center Hospital, Niigata, Japan · Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan · Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan · Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan · Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Cellular(HSC) Medicine - Oncology(HSC) Medicine - Rehabilitation/Therapy
Citation lifecycle

How this paper is being cited

Pre-retraction
1
Same day
0
Post-retraction
5
% post-retraction
83.3%
~1.1 citations/yr before retraction · ~0.8 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse